Rose N - Search Results

1

Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV.

Van Rompay KK, Abel K, Earl P, Kozlowski PA, Easlick J, Moore J, Buonocore-Buzzelli L, Schmidt KA, Wilson RL, Simon I, Moss B, Rose N, Rose J, Marthas ML. Van Rompay KK, et al. Among authors: rose j, rose n. Vaccine. 2010 Feb 10;28(6):1481-92. doi: 10.1016/j.vaccine.2009.11.061. Epub 2009 Dec 6. Vaccine. 2010. PMID: 19995539 Free PMC article.

2

Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge.

Schell J, Rose NF, Fazo N, Marx PA, Hunter M, Ramsburg E, Montefiori D, Earl P, Moss B, Rose JK. Schell J, et al. Among authors: rose jk, rose nf. Vaccine. 2009 Feb 11;27(7):979-86. doi: 10.1016/j.vaccine.2008.12.017. Epub 2009 Jan 7. Vaccine. 2009. PMID: 19135115 Free PMC article.

3

Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques.

Marthas ML, Van Rompay KK, Abbott Z, Earl P, Buonocore-Buzzelli L, Moss B, Rose NF, Rose JK, Kozlowski PA, Abel K. Marthas ML, et al. Vaccine. 2011 Apr 12;29(17):3124-37. doi: 10.1016/j.vaccine.2011.02.051. Epub 2011 Mar 4. Vaccine. 2011. PMID: 21377510 Free PMC article.

4

Transmitted/founder simian immunodeficiency virus envelope sequences in vesicular stomatitis and Semliki forest virus vector immunized rhesus macaques.

Gambhira R, Keele BF, Schell JB, Hunter MJ, Dufour JP, Montefiori DC, Tang H, Rose JK, Rose N, Marx PA. Gambhira R, et al. Among authors: rose jk, rose n. PLoS One. 2014 Oct 31;9(10):e109678. doi: 10.1371/journal.pone.0109678. eCollection 2014. PLoS One. 2014. PMID: 25360552 Free PMC article.

5

Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol.

Ramsburg E, Rose NF, Marx PA, Mefford M, Nixon DF, Moretto WJ, Montefiori D, Earl P, Moss B, Rose JK. Ramsburg E, et al. J Virol. 2004 Apr;78(8):3930-40. doi: 10.1128/jvi.78.8.3930-3940.2004. J Virol. 2004. PMID: 15047809 Free PMC article.

6

Viral vectored granulocyte-macrophage colony stimulating factor inhibits vaccine protection in an SIV challenge model: protection correlates with neutralizing antibody.

Schell JB, Bahl K, Rose NF, Buonocore L, Hunter M, Marx PA, LaBranche CC, Montefiori DC, Rose JK. Schell JB, et al. Vaccine. 2012 Jun 13;30(28):4233-9. doi: 10.1016/j.vaccine.2012.04.046. Epub 2012 Apr 23. Vaccine. 2012. PMID: 22537983 Free PMC article.

7

Antigenic requirement for Gag in a vaccine that protects against high-dose mucosal challenge with simian immunodeficiency virus.

Schell JB, Bahl K, Folta-Stogniew E, Rose N, Buonocore L, Marx PA, Gambhira R, Rose JK. Schell JB, et al. Among authors: rose jk, rose n. Virology. 2015 Feb;476:405-412. doi: 10.1016/j.virol.2014.12.027. Epub 2015 Jan 12. Virology. 2015. PMID: 25591175 Free PMC article.

8

Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1.

Rose NF, Roberts A, Buonocore L, Rose JK. Rose NF, et al. Among authors: rose jk. J Virol. 2000 Dec;74(23):10903-10. doi: 10.1128/jvi.74.23.10903-10910.2000. J Virol. 2000. PMID: 11069984 Free PMC article.

9

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants.

Rose NF, Marx PA, Luckay A, Nixon DF, Moretto WJ, Donahoe SM, Montefiori D, Roberts A, Buonocore L, Rose JK. Rose NF, et al. Among authors: rose jk. Cell. 2001 Sep 7;106(5):539-49. doi: 10.1016/s0092-8674(01)00482-2. Cell. 2001. PMID: 11551502 Free article.

10

Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes.

Egan MA, Chong SY, Rose NF, Megati S, Lopez KJ, Schadeck EB, Johnson JE, Masood A, Piacente P, Druilhet RE, Barras PW, Hasselschwert DL, Reilly P, Mishkin EM, Montefiori DC, Lewis MG, Clarke DK, Hendry RM, Marx PA, Eldridge JH, Udem SA, Israel ZR, Rose JK. Egan MA, et al. AIDS Res Hum Retroviruses. 2004 Sep;20(9):989-1004. doi: 10.1089/aid.2004.20.989. AIDS Res Hum Retroviruses. 2004. PMID: 15585086

An experimental AIDS vaccine based on attenuated, recombinant vesicular stomatitis virus (rVSV), when administered by a combination of parenteral and mucosal routes, has proven effective at preventing AIDS in a rhesus macaque model (Rose NF, et al.: Cell 2001;106:539-549). …

An experimental AIDS vaccine based on attenuated, recombinant vesicular stomatitis virus (rVSV), when administered by a combination of paren …

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,294 results

Search Page